Advertisement

Topics

Correction of a pathogenic gene mutation in human embryos

06:52 EDT 3 Aug 2017 | Nature Publishing

CRISPR–Cas9 genome editing is used to induce a DNA repair response and correct a disease-causing heterozygous mutation in human embryos with reduced mosaicism and preferential repair using the wild-type copy of the gene.

Original Article: Correction of a pathogenic gene mutation in human embryos

NEXT ARTICLE

More From BioPortfolio on "Correction of a pathogenic gene mutation in human embryos"

Quick Search
Advertisement
 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...